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ABSTRACTSwere required to detect one cancer, while 124 screening mammog-
rams(costing £4340) were required to detect one cancer.
Conclusions: Routine annual mammograms for breast cancer recurrence
are less cost effective than those for the NHSBCSP. Stratiﬁed follow up or
less frequent mammograms should be considered for detecting recur-
rence.
1057: DO YOUNG WOMEN WITH CLINICALLY AND RADIOLOGICALLY
BENIGN BREAST LUMPS REQUIRE BIOPSIES?
Deepak Vijayan, Kolitha Goonetilleke, Kiren Virdee, Nikhal Sharma, Martin
Sintler. Sandwell General Hospital, Birmingham, UK
Aim: Women <25 years with clinically and radiologically benign breast
lumps do not require a biopsy in accordance with RCR guideline 2010.
Methods: A retrospective audit of all women under 30 years having
a breast biopsy at SWBH NHS Trust between Jan 2000 and Dec 2010.
Clinical, radiological and histological data were compared.
Results: 864 patients were identiﬁed from the pathology database, 612
had FNAC and 252 had core biopsy. 544 patients had full data sets available
for analysis. 91.2% (496) were p2 u2, all were conﬁrmed b2 histology. 7.2%
(39) were p2+ u3 with histology downgrading all of them to b2. 1.7% (9)
were p3+ u3+ and histology graded them as b4+. 61.4% (334) of the dataset
< 25years old. 10 cancers were detected, 1 <25 yrs (P2 U2), 9 >25yrs all
suspicious clinically and radiologically.
Conclusions: 91.2% of biopsies could have been avoided. Clinical and
Radiological ﬁndings show a high correlation < 30 years. Only 0.18% (1)
showed a discrepancy from the guidelines. 8.8% of the patients would
have required biopsies in keeping with the guidelines; a substantial
saving in psychological stress to patients, ﬁnancial cost and manpower
time.
1071: IMPROVING THE SERVICE FOR PATIENTS WITH BENIGN BREAST
BIOPSY RESULTS: LESSONS LEARNT FROM A BUSY DISTRICT GENERAL
HOSPITAL
Richard Boulton 1, Shanjitha Kantharuban 2, Ruth James 2, Kian
Chin 2, Amanda Taylor 2. 1North Middlesex University Hospital, London, UK,;
2Milton Keynes Foundation Hospital, Milton Keynes, Buckinghamshire, UK
Aims: In 2005 the NHS Breast Screening Programme published guidelines
recommending that 90% of breast biopsy results should be given to
patients within a week.
We set up a Consultant-led telephone biopsy results service in response to
a recent questionnaire study that demonstrated 77% of our patients did not
want a follow up appointment if their biopsy result was benign. Our
experience and audit results are presented below.
Methods: Retrospective analysis of 25 under 35 year clinic patients with
benign histology between August 2009 and February 2010, and prospec-
tive analysis of 35 patients identiﬁed as suitable for telephone results in
July 2010.
Results: Between August 2009 and February 2010 the average wait from
appointment to the patient receiving benign biopsy results were 25 days
(16-61). 0% of patients were informed within a week. The average wait for
results via telephone call was 6 days (2-12), with 88% (31/35) receiving
results in 7 days or less.
Conclusions: There was a signiﬁcant reduction in patient wait for benign
histology results after the introduction of a Consultant-led telephone
service, which approached the NHSBSP target of 90%. This has reduced
patient anxiety, clinic attendances and net departmental workload with
resultant ﬁnancial savings.
1077: AN ANALYSIS OF EMERGENCY ADMISSIONS RELATED TO PRIMARY
BREAST SEPSIS: A THREE-YEAR STUDY
George Kerans, Zoe Lin, Debasish Debnath, Lorna Cook, Isabella
Karat, Raouf Daoud, Ian Laidlaw. Frimley Park Hospital, Frimley, Surrey, UK
Aim: Factors related to emergency admission of primary breast sepsis are
not well known. We aimed to evaluate any such underlying factors.
Method: Analysis of all emergency breast-related emergency admissions
from 1st January 2009 to 31st December 2011 was performed retrospec-
tively. Statistical analysis was performed using SPSS 16.0.
Results: Some 140 breast-related emergency admissions took place over
a three year period. A total of 89 admissions (59.7%) were due to primarybreast sepsis (either cellulites or abscess, unrelated to any recent breast
intervention). Patients with primary breast sepsis were signiﬁcantly
younger (40.916.1 years), compared to those who were admitted with
other breast emergencies (such as haematoma, postoperative wound
infection, pain, seroma, etc.) (53.415.0 years) [p<0.001]. Monthly
occurrence of primary breast sepsis was highest in July (n¼14) and lowest
in September (n¼3) [p¼0.06]. Seasonal occurrences of primary breast
sepsis were as follows- winter (18), spring (20); summer (29) and autumn
(22) [p¼0.29].
Conclusions: Incidence of primary breast abscess requiring emergency
admission remained moderate and peaked in July and summer. Patients
with primary breast sepsis were signiﬁcantly younger than those without.
These may improve our current understanding and have implications on
service provision.
1079: AN AUDIT OF PRE-OPERATIVE AXILLARY ULTRASOUND
ASSESSMENT IN BREAST CANCER
Matthew Green, Ani Tencheva, Hemant Ingle, Jamie McIntosh. Good Hope
Hospital, Sutton Coldﬁeld, UK
Aim: To assess the sensitivity and speciﬁcity of pre-operative axillary
ultrasound in predicting lymph node metastases in breast cancer.
Method: A retrospective review of patients undergoing surgery for breast
cancer over a 12-month study period was undertaken. Data was collected
on pre-operative lymph node radiology, cytology and histopathology and
correlated with post-operative histological nodal status.
Out of 93 patients, 31 had radiologically abnormal axillary ultrasound
scans (group 1) whilst 62 were normal (group 2).
In group 1- 2 patients underwent ultrasound-guided biopsy of node, 3
underwent sentinel lymph node biopsy (SLNB), 28 underwent primary
axillary node clearance (ANC) and 1 underwent secondary ANC (following
SLNB).
In group 2- 47 underwent SLNB, 15 underwent primary ANC and 11
underwent secondary ANC
Results: In group 1, 87% of patients had involved nodes comparedwith 39%
of patients in group 2. This data gives the sensitivity of ultrasound scan of
the axilla as 52.9%, a speciﬁcity of 90.5%, positive predictive value of 87.1%
and a negative predictive value of 61.3%.
Conclusions: Isolated ultrasound assessment of axillary lymph nodes has
an unacceptably low sensitivity, although speciﬁcity is high. Sensitivity
may be improved by combining pre-operative imaging with guided lymph
node biopsies.
1093: INVESTIGATING THE IMPACT OF NEOADJUVANT CHEMOTHERAPY
AND HERCEPTIN ON THE SURGICAL MANAGEMENT OF PATIENTS WITH
INVASIVE BREAST CANCER
Terri McVeigh, Dhaﬁr Al-Azawi, Karl Sweeney, Carmel Malone, Maccon
Keane, Ray McLaughlin, Michael Kerin. Galway University Hospital,
Galway, Ireland
Aims: Neoadjuvant Chemotherapy(NCT) is indicated in locally aggressive
invasive breast cancers. The aims of this study are to audit the surgical
management of patients managed with NCT, including Herceptin, in
a tertiary referral centre in the west of Ireland, and to assess the impact of
receptor status on response to chemotherapy.
Methods: The cohort studied included all patients assigned to NCT
between 1999-2010. Data regarding patient demographics, tumour char-
acteristics, nodal management, ﬁnal pathological score and outcome was
obtained from a prospectively maintained database. Analysis was
completed using PASWv18.
Results: 152 patients were assigned to NCT including 5 with bilateral
disease. Following chemotherapy, 140 patients underwent Axillary Clear-
ance(AXCn), of which 53 were negative. NCT was found to be effective in
77.9% of patients, 29.3% having a complete pathological response, and
a further 48.6% having partial response. Breast Conservationwas facilitated
in 42 patients(28.57%). Luminal-A subtypewas themolecular subtypemost
often associated with a poor response (30.14%), while all those positive for
Her-2 receptor had at least a partial response, 50% a complete response.
Conclusion: AXCn in this cohort remains controversial, with 38% of
patients assigned to AXCn with no additional positive lymph node yield.
Those patients treated with chemotherapy targeting Her2-receptor had
a better response than Her2-negative patients.
